-
Uncategorized1 month agoSTAT+: Drug meant to make gene therapy safer may also make it less effective
BOSTON — A medicine increasingly used to mitigate the risk of deadly gene therapy side effects could also blunt the therapy’s effectiveness, a new study finds....
-
Uncategorized1 month agoOpinion: Access to air conditioning is critical preventive care. But federal policy treats it as optional
During the first heat wave of 2025, 55-year-old Shauna Thomas was found dead in her suburban St. Louis apartment after spending at least three days without...
-
Uncategorized1 month ago
STAT+: Bill Cassidy risked his legacy. It may not be enough to save his career
BATON ROUGE, La. — When it comes to Bill Cassidy, most everyone in Louisiana politics — supporters and detractors alike — feels bad for the senator....
-
Uncategorized1 month ago
Scientist as strategist: expanding the role beyond the bench
Scientist as strategist: expanding the role beyond the bench
-
Uncategorized1 month ago
Mid-sized European drugmakers are snapping up US biotechs. Will the surge continue?
European pharma companies splashed billions of dollars into the U.S. biopharma sector in a matter of days, but there are differing views on whether the activity...
-
Uncategorized1 month ago
Lilly, J&J CEOs top pharma’s highest paid list—again
Three pharma CEOs joined the $30 million compensation club in 2025 but Eli Lilly’s David Ricks exceeded his nearest peer by more than $4 million.
-
Uncategorized1 month ago
AstraZeneca pens agentic AI licensing deal with Owkin
AstraZeneca is the latest Big Pharma company looking to tap into agentic artificial intelligence (AI), inking a three-year licensing deal with Owkin to leverage its autonomous...
-
Uncategorized1 month ago
10x Genomics, Harvard Target Element’s Multiomics Platform in Patent Lawsuit
10x Genomics and Harvard University have sued Element Biosciences, alleging that Element’s AVITI24 multiomics platform, Teton chemistry, and related services infringe on four university-owned patents exclusively...
-
Uncategorized1 month ago
A rare cancer-fighting plant compound has been decoded
Scientists at UBC Okanagan have uncovered how plants produce mitraphylline, a rare natural compound with promising anti cancer potential. The team identified two enzymes that work...
-
Uncategorized1 month ago
Immune-remodeling mRNAs expressing IRF8 or NIK generate durable antitumor immunity in multiple cancer models
Nature Biotechnology, Published online: 13 May 2026; doi:10.1038/s41587-026-03115-2 Immune-remodeling mRNAs delivered in lipid nanoparticles boost antitumor immunity.
